1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Acute Myeloblastic Leukemia: new trials by email Literature Review of Acute Myeloblastic Leukemia trials Research Report on Acute Myeloblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant Alentuzumab, Globulina antilinfocitaria - Acute Myeloblastic Leukemia, Lymphoblastic Leukemia | Phase 2 / Phase 3 | Completed | Gruppo Italiano Trapianto di Midollo Osseo | 121 | 2005-03-01 | 2023-03-10 |
Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Primary Myelofibrosis (1)
Anemia (1) · Anemia, Refractory (1) · Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Leukemia, Myeloid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Myelodysplastic Syndromes (1)
Gruppo Italiano Trapianto di Midollo Osseo (1)
Italy (1)